Patient-initiated follow-up for high-risk cutaneous squamous cell carcinoma: how we do it and 2 years of outcome data
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Patient-initiated follow-up (PIFU) is a safe alternative for high-risk cutaneous squamous cell carcinomas (cSCC) patients. This approach allows patients to seek care when needed, optimizing healthcare resources and potentially improving patient outcomes.
Area Of Science
- Dermatology
- Oncology
- Health Services Research
Background
- Current guidelines recommend 24-month follow-up for high-risk cutaneous squamous cell carcinomas (cSCC).
- Evidence suggests recurrence and metastasis are rare, questioning the necessity of intensive follow-up schedules.
- Intense follow-up may not significantly improve health outcomes for cSCC patients.
Purpose Of The Study
- To evaluate the safety and efficacy of patient-initiated follow-up (PIFU) for high-risk cSCC.
- To determine if PIFU can replace traditional scheduled follow-up appointments.
- To assess the impact of PIFU on healthcare resource utilization.
Main Methods
- 476 patients with high-risk cSCC were enrolled between January 2020 and January 2023.
- Patients were offered a PIFU pathway instead of routine follow-up.
- Data collected on patient re-contact, clinical outcomes, and appointment utilization.
Main Results
- 35.1% of patients utilized the PIFU pathway, with 119 requiring only one appointment.
- 250 patients (52.5%) did not recontact during the 2-year period, with no reported complications or recurrences.
- Significant cost savings of £181,462.50 were realized by avoiding 1250 scheduled appointments.
Conclusions
- PIFU is a safe and viable alternative for managing high-risk cSCC patients.
- Patients can effectively self-identify the need for review, reducing unnecessary appointments.
- Findings support revising current skin cancer policies to incorporate PIFU for improved patient care and resource allocation.
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
Related Concept Videos
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
Survival Times Are Positively Skewed
Survival times often exhibit positive skewness, unlike the normal distribution assumed...